Application of the Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide the empiric antibiotic treatment of febrile neutropenia in oncological paediatric patients: experience from two paediatric hospitals in Northern Italy

Cecilia Liberati,Daniele Donà,Linda Maestri,Maria Grazia Petris,Elisa Barbieri,Elisa Gallo,Jacopo Gallocchio,Marta Pierobon,Elisabetta Calore,Annachiara Zin,Giulia Brigadoi,Marcello Mariani,Alessio Mesini,Carolina Saffioti,Elisabetta Ugolotti,Dario Gregori,Carlo Giaquinto,Elio Castagnola,Alessandra Biffi
DOI: https://doi.org/10.1186/s12941-024-00673-8
2024-02-16
Annals of Clinical Microbiology and Antimicrobials
Abstract:Guidelines about febrile neutropenia in paediatric patients are not homogeneous; the best empiric treatment of this condition should be driven by local epidemiology. The Weighted-Incidence Syndromic Combination Antibiogram (WISCA) addresses the need for disease-specific local susceptibility evidence that could guide empiric antibiotic prescriptions based on outcome estimates of treatment regimens obtained as a weighted average of pathogen susceptibilities. This study developed a WISCA model to inform empirical antibiotic regimen selection for febrile neutropenia (FN) episodes in onco-haematological paediatric patients treated at two Italian paediatric tertiary centres.
microbiology
What problem does this paper attempt to address?